Showing 1 - 12 results of 12 for search 'M. Rijken', query time: 0.04s
Refine Results
-
1
-
2
-
3
Characterization of Forearm Muscle Activation in Duchenne Muscular Dystrophy via High-Density Electromyography: A Case Study on the Implications for Myoelectric Control by Kostas Nizamis, Noortje H. M. Rijken, Robbert van Middelaar, João Neto, Bart F. J. M. Koopman, Massimo Sartori
Published 2020-04-01
Article -
4
-
5
-
6
Challenges of implementing tenofovir disoproxil fumarate in pregnancy for prevention of hepatitis B mother to child transmission in a rural population by M. Bierhoff, W. Yotyingaphiram, M. Pimanpanarak, M. van Vugt, M. Rijken, C. Angkurawaranon, F. Nosten, S. Ehrhardt, C. Thio, R. McGready
Published 2020-12-01
Article -
7
P406: ENHANCED SIGNIFICANCE OF FLT3-ITD RESIDUAL DISEASE DETECTION ON TREATMENT OUTCOME IN ACUTE MYELOID LEUKEMIA by T. Grob, M. Sanders, C. Vonk, F. Kavelaars, M. Rijken, D. Hanekamp, P. Gradowska, J. Cloos, Y. Fløisand, M. V. Marwijk Kooy, M. Manz, G. Ossenkoppele, L. Tick, V. Havelange, B. Löwenberg, M. Jongen-Lavrencic, P. Valk
Published 2022-06-01
Article -
8
Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms by Nisha Sharma, Annie Y. Ng, Jonathan J. James, Galvin Khara, Éva Ambrózay, Christopher C. Austin, Gábor Forrai, Georgia Fox, Ben Glocker, Andreas Heindl, Edit Karpati, Tobias M. Rijken, Vignesh Venkataraman, Joseph E. Yearsley, Peter D. Kecskemethy
Published 2023-05-01
Article -
9
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia by P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin
Published 2023-07-01
Article -
10
Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases by Nina J. Wesdorp, J. Michiel Zeeuw, Sam C. J. Postma, Joran Roor, Jan Hein T. M. van Waesberghe, Janneke E. van den Bergh, Irene M. Nota, Shira Moos, Ruby Kemna, Fijoy Vadakkumpadan, Courtney Ambrozic, Susan van Dieren, Martinus J. van Amerongen, Thiery Chapelle, Marc R. W. Engelbrecht, Michael F. Gerhards, Dirk Grunhagen, Thomas M. van Gulik, John J. Hermans, Koert P. de Jong, Joost M. Klaase, Mike S. L. Liem, Krijn P. van Lienden, I. Quintus Molenaar, Gijs A. Patijn, Arjen M. Rijken, Theo M. Ruers, Cornelis Verhoef, Johannes H. W. de Wilt, Henk A. Marquering, Jaap Stoker, Rutger-Jan Swijnenburg, Cornelis J. A. Punt, Joost Huiskens, Geert Kazemier
Published 2023-12-01
Article -
11
Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial by Karen Bolhuis, MD, Lodi Grosheide, MD, Nina J. Wesdorp, MD, Aysun Komurcu, MSc, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk J. Grünhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, Joost Huiskens, MD, PhD, Koert P. De Jong, MD, PhD, Geert Kazemier, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Cornelis J. A. Punt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel
Published 2021-09-01
Article -
12
The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment by Nina J. Wesdorp, MD, Karen Bolhuis, MD, Joran Roor, MSc, Jan-Hein T. M. van Waesberghe, MD, PhD, Susan van Dieren, MSc, PhD, Martin J. van Amerongen, MD, PhD, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Marc R. W. Engelbrecht, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk Grunhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, John J. Hermans, MSc, MD, PhD, Koert P. de Jong, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, Krijn P. van Lienden, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, Cornelis J. A. Punt, MD, PhD, Joost Huiskens, MD, PhD, Geert Kazemier, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel
Published 2021-12-01
Article